Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Breast Neoplasms 9 Prostatic Neoplasms 4 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Pain, Postoperative 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Fallopian Tube Neoplasms 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Lymphoma 2 Hemorrhage 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thromboembolism 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Peritoneal Neoplasms 1 Peripheral Nervous System Diseases 1 Pancreatic Cyst 1 Pain 1 Non-Muscle Invasive Bladder Neoplasms 1 Neurotoxicity Syndromes 1 Myofibroma 1 Multiple Myeloma 1 Metabolic Diseases 1 Melanoma 1

Interventions

pembrolizumab 2 cemiplimab 1 avelumab 1 atezolizumab 1 Saline Solution 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Merkel Cell × Saline Solution × Clear all

NCT03271372 2026-05-12

ADAM

University of Washington

Phase 3 Active not recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡